Susceptibility to infectious diseases based on antimicrobial peptide production.
about
Current and potential applications of host-defense peptides and proteins in urologyAbility of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal modelsDefensins as anti-inflammatory compounds and mucosal adjuvantsInfluence of diabetes mellitus on the immunity to human tuberculosis.Microbial colonization and ureteral stent-associated storage lower urinary tract symptoms: the forgotten piece of the puzzle?Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes.Effect of recombinant prophenin 2 on the integrity and viability of Trichomonas vaginalisEffects of a single nucleotide polymorphism in the chicken NK-lysin gene on antimicrobial activity and cytotoxicity of cancer cells.Understanding the roles of gingival beta-defensins.Probiotics for human lactational mastitis.P. gingivalis in Periodontal Disease and Atherosclerosis - Scenes of Action for Antimicrobial Peptides and Complement.Calcitriol prevents inflammatory gene expression in macrovascular endothelial cells.Genetic variation in the promoter region of beta-defensin 1 (DEFB 1) is associated with high caries experience in children born with cleft lip and palate.Current insights into the role of human β-defensins in atopic dermatitis.Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment.Vaccine research and development: tuberculosis as a global health threat.Effect of vitamin D3 on the antimicrobial activity of human airway surface liquid: preliminary results of a randomised placebo-controlled double-blind trial.Human neutrophil peptide-1 decreases during ageing in selected Mexican population.Structural glance into a novel anti-staphylococcal peptide.IL-36/LXR axis modulates cholesterol metabolism and immune defense to Mycobacterium tuberculosis.Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways.Inhibitory effects of Lactobacillus fermentum on microbial growth and biofilm formation.Variation in Streptococcus pneumoniae susceptibility to human antimicrobial peptides may mediate intraspecific competition
P2860
Q27027719-9CD88123-8444-403C-B3BD-3376E8264368Q28488709-68499758-F8F5-4063-9F03-78F5E148AC55Q28748926-9D226B98-901B-4346-BDB2-9EF966246478Q30234363-F97F0C9B-D555-479E-B331-04B511C99B8CQ33353146-5C8F59D2-9BEC-4836-BC83-382C94BE400AQ34739899-EA82A49A-C16B-40BA-A0D8-FD2B218D71D6Q35177948-18097702-4CE8-46CD-93E3-6E2DE2AAABB3Q36132580-7CFADC29-2B2E-4FE4-BEC7-A9244D8B787BQ37990507-302F2CCE-5EE6-4BA7-B26C-C87F72E5FEEEQ38181858-32B6BB2A-D6D6-4574-A47A-936AE04AB0F2Q38365016-E34EFE6C-3A95-403C-8688-9FC02CDBD9F0Q38770764-85BC2D07-77EE-413F-A723-6F753DE3DF72Q39363695-D9E7191F-2558-490D-826E-AAE08E595691Q39435059-9A81E2A3-BCED-4E51-BFAD-14D787BE459EQ40046257-C2EC04A8-0DEF-40D2-9DDD-03DBA033978CQ40059597-ED2638A4-DB33-48FC-88F8-2A0171AC154EQ40061371-AE8D3886-C4B1-4F3A-8A07-0FBB22FF0BFCQ41023709-C8B49C03-B8F0-4271-A3BC-CAB4314BCB9EQ45391832-BD293F71-4BC6-4941-85B1-CE1EC7B9989FQ48171842-878C5477-C45F-45C3-95AB-376F7C927FC5Q48219322-5F119FE3-67CB-4FC9-8133-BA490703BF10Q52662684-BC44DCB9-FCEC-4301-87E4-4D867118F061Q58493810-9750512A-0FC3-43A2-9FF8-77B1E703F5B3
P2860
Susceptibility to infectious diseases based on antimicrobial peptide production.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Susceptibility to infectious diseases based on antimicrobial peptide production.
@en
Susceptibility to infectious diseases based on antimicrobial peptide production.
@nl
type
label
Susceptibility to infectious diseases based on antimicrobial peptide production.
@en
Susceptibility to infectious diseases based on antimicrobial peptide production.
@nl
prefLabel
Susceptibility to infectious diseases based on antimicrobial peptide production.
@en
Susceptibility to infectious diseases based on antimicrobial peptide production.
@nl
P2093
P2860
P356
P1476
Susceptibility to infectious diseases based on antimicrobial peptide production.
@en
P2093
Bruno Rivas-Santiago
Carmen J Serrano
J Antonio Enciso-Moreno
P2860
P304
P356
10.1128/IAI.01515-08
P407
P577
2009-08-24T00:00:00Z